Superworth

Artiva Biotherapeutics market cap ARTV

Share price times shares outstanding: what the whole company sells for, since 2024.

Today, Nov 2, 2026
$204.8M
Highest close in our data
$559.8M
Aug 2026

Artiva Biotherapeutics is worth $204.8M at the close on Nov 2, 2026, at $4.19 a share.

That is up 142% over the last year.

Its highest close in our data was $559.8M in Aug 2026.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$204.8M$95.5M$559.8M+100%
2025$102.6M$35.8M$259.2M−60%
2024$258.4M$241.9M$384.5Mn/a

Against its peers

Companies in Healthcare nearest Artiva Biotherapeutics' size, closest first, today.

CompanyMarket cap
ARTVArtiva Biotherapeutics$204.8M
PLXProtalix BioTherapeutics$206.3M
NATRNatures Sunshine Products$211.5M
ELMDElectromed$223.9M
UTMDUtah Medical Products$224.6M
PDEXPro DEX$184.5M
INFUInfuSystem$275.7M
CYHCommunity Health Systems$296.2M
EMBCEmbecta$350.7M
VMDViemed Healthcare$359.6M
CRMDCorMedix$420.1M
Peer median$250.1M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Artiva Biotherapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.